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OBJECTIVE: The objective of this selective EBM review is to determine whether or not 
cognitive behavioral therapy is effective in alleviating IBS-related symptoms experienced by 
patients with irritable bowel syndrome.
STUDY DESIGN: A systematic review of three randomized controlled trials (RCTs) that were 
published in peer-reviewed journals in 2009, 2010, and 2018, all in the English language.
DATA SOURCES: All three studies discussed in this systematic review were found and 
accessed using PubMed. 
OUTCOME MEASURED: Reduction of IBS symptoms as measured by the IBS-SSS 
questionnaire and the IBS symptom score analysis. 
RESULTS: All three studies yielded a statistically significant reduction (p<.05) in IBS 
symptoms through sessions of cognitive behavioral therapy. 
CONCLUSIONS: CBT is an effective treatment option that can reduce anxiety and internal 
conflict, which may be a contributory or causative agent in IBS patients. The evidence presented 
within each of the three studies analyzed in this review suggests that cognitive behavioral 
therapy is an effective intervention to alleviate discomfort in patients with irritable bowel 
syndrome. 
KEY WORDS: Cognitive therapy, CBT, cognitive behavioral therapy, cognitive behavioural 
therapy, behavioral therapy, behavioural therapy, irritable bowel syndrome, IBS 
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INTRODUCTION 
Irritable bowel syndrome (IBS) is a common condition that affects the large intestine. 
The typical patient may experience symptoms such as abdominal pain, nausea, flatus, diarrhea, 
and/or constipation. Patients with this disorder may experience some or all of these symptoms, 
with severity ranging from mild to debilitating. This disorder is more common amongst females, 
and affects approximately 25-45 million people in the United States.1 Additionally, IBS is known
to affect the younger population more significantly, and may be influenced by genetics and 
environmental disposition. It is estimated that there are 3.5 million healthcare visits annually 
attributable to IBS.2 Therefore, providers of all specialties will likely encounter IBS at some 
point within their careers. The workup for this diagnosis can be quite extensive, as there is no 
specific test for IBS, and thus it is a diagnosis of exclusion. A typical GI workup for IBS will 
include obtaining a complete history and physical exam, stool testing, gluten intolerance testing, 
flexible sigmoidoscopy or colonoscopy, x-ray or CT scanning. Due to this extensive testing, the 
cost associated with IBS medications and indirect costs have been estimated at 21 billion dollars 
annually in the United States alone.3 After a provider rules out other potential diagnoses such as 
ulcerative colitis, crohns disease, bowel obstruction, or other potentially serious conditions, a 
diagnosis of IBS may be appropriate.
There is much yet to learn about this diagnosis. For example, the exact pathophysiology 
of this common disorder has perplexed researchers for centuries. The reason for this is in part 
due to the complex physiology associated with the enteric nervous system, and how it may be 
influenced by external factors such as emotion, diet, and genetics. Furthermore, the gut 
microbiota of an individual is responsible for producing a variety of neuroactive molecules, 
which communicate with the brain to execute physiologic functions. This communication 
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between the gut and the brain is bidirectional. The brain affects the gut primarily through the 
central nervous system and endocrine system. Consequentially, the gut is significantly affected 
by factors that impact the brain, and dynamics within the brain. Therefore, ones mental health 
may have a profound degree of influence on their guts functioning. 
Gastrointestinal disturbances are a common complaint amongst patients experiencing 
increased levels of anxiety. The specific cause remains unknown, but it may be due in part to the 
fact that this population has a colon that is hypersensitive to stress. Research has shown that 50 
to 90 percent of IBS patients who seek treatment have a comorbid psychiatric condition such as 
anxiety or depression.4 Therefore, mental health conditions may predispose one to an increased 
chance of developing irritable bowel syndrome. Conversely, IBS may also increase anxiety or 
depression, as it can significantly impair ones daily activities and overall quality of life. 
There currently is no cure for this disorder, but there are a number of ways one can 
manage this condition. Perhaps the most obvious and initial treatment one should employ, is 
avoidance of the dietary factors that are known to cause one distress. Additionally, other lifestyle
changes such as a high fiber diet, adequate hydration, a regular exercise schedule, as well as a 
healthy sleep schedule can contribute to the reduction of symptoms.5 As far as pharmalogical 
treatment of IBS is concerned, there are a number of different options available. The most 
appropriate treatment will correlate with the specific symptoms and severity that one is 
experiencing. These classes of medications include laxatives, anticholinergic medications, 
tricyclic antidepressants, SSRI antidepressants, pain medications, Alosetron, Eluxadoline, 
Rifaximin, Lubiprostone and Linactolide.5 Researchers continue to work tirelessly to develop 
new medications to combat this syndrome. For instance, researchers speculate that future 
treatments may involve serum-derived bovine immunoglobulin/protein isolate (SBI) and enteric 
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coated peppermint oil for successful treatment of diarrhea in certain patients with IBS.5 
Psychological interventions such as cognitive behavioral therapy, mindfulness exercises, 
hypnosis, and various forms of relaxation therapy may also be of benefit in the treatment of IBS. 
The primary focus of these interventions is to utilize the mind as a tool to reduce the negative 
effects that the brain produces on the gut. Cognitive behavioral therapy is a specific type of 
psychotherapy a therapist can employ to help a patient manage negative thinking or emotional 
challenges in a more constructive way. This can ultimately reduce anxiety by teaching one 
effective methods to manage their personal stressors. This paper serves to evaluate three 
randomized controlled trials (RCTs) to evaluate the potential efficacy of CBT in IBS patients. 
OBJECTIVE
The objective of this selective EBM review is to determine whether or not cognitive 
behavioral therapy is effective in alleviating IBS-related symptoms experienced by patients with 
irritable bowel syndrome.
METHODS  
Three RCTs were chosen based on their relevance and ability to answer the objective. 
The first RCT completed by Moss-Morris et al. investigates patients meeting Rome I and Rome 
II criteria between the ages of 18-72 who can read and write English.6 The intervention applied 
to the participants in this study was a seven week manualized program of CBT that is self-
administered in conjunction with a one hour face to face therapy session, and two one hour 
phone sessions.6 These patients were compared to a control group of treatment as usual patients 
with IBS.6 The outcome that was measured in this study is IBS symptom relief as measured by 
the irritable bowel syndrome severity scoring system questionnaire or IBS-SSS.6 
The second study done by Jarrett et al. is a three-arm randomized controlled trial, which 
Ambrose, IBS Reduction with CBT 4
studied adults with IBS recruited through community advertisement.7 The intervention applied to
this population is CBT through nine weekly in-person comprehensive self-management 
sessions.7 This population was compared to a control group of IBS patients that were receiving 
their usual care.7 The outcome measured in this study is the IBS symptom score, which consists 
of 26 IBS symptoms, that were rated on a scale of 0-4.7
The third study done by Lackner et al. is a randomized controlled parallel group trial 
studying individuals 18-70 years of age whom are diagnosed with Rome III criteria IBS who 
receive CBT.8 The intervention specifically is a group receiving standard-CBT with ten weekly 
sixty-minute sessions.8 They were compared against a control group of patients with IBS that 
received four information sessions about IBS and the role of lifestyle factors.8 The outcome of 
this study was measured by the irritable bowel syndrome symptom severity scale, or IBS-SSS.8
Each of the three articles chosen for this systematic review were personally discovered, 
and accessed from the PubMed database. They were all published within the last ten years, in 
English, and within peer-reviewed journals.6,7,8 They were discovered by searching the following 
keywords: “Cognitive therapy, CBT, Cognitive behavioral therapy, cognitive behavioural 
therapy, behavioral therapy, behavioural therapy, irritable bowel syndrome, IBS.” The articles 
were selected upon their relevance and ability to answer my proposed clinical question. The 
inclusion criteria used for my search consisted of studies published after 2009, randomized 
controlled trials, human study participants, and outcomes presented as patient oriented evidence 
that matters. The exclusion criteria used for my search consisted of animal study participants, 
and studies published earlier than 2009.  The three studies all present non-dichotomous data, and 
the following statistics were reported and analyzed to make assumptions of treatment efficacy: 
mean change from baseline, p-values, CI’s and OR’s.
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OUTCOMES MEASURED 
The outcome of interest in each of the three studies is reported as patient oriented 
evidence that matters (POEM). Many different outcomes were assessed throughout each of the 
three studies. However, the primary focus of this review will be on IBS symptom reduction 
reported through questionnaires. The study by Moss-Morris et al. utilized the IBS-SSS and had 
patients return questionnaires at baseline, end of treatment, three months post-treatment, and six 
months post-treatment. The study by Jarrett et al. utilized the IBS symptom score questionnaire 
at baseline, three months post treatment, six months post-treatment, and twelve months post-
treatment. The study by Lackner et al. measured the outcome through the IBS-SSS at baseline, 
three months post treatment, and six months post-treatment. 
RESULTS
The three studies analyzed in this systematic review present continuous data that is 
unable to be converted to dichotomous data. Though the RCTs are all focused on reduction of 
IBS symptoms through CBT, the experimental designs are slightly different in each study. 
Additionally, the data is analyzed with a variety of differing statistical analyses throughout each 
of the studies. The mean change from baseline in regard to symptomatic reduction in IBS 
symptom severity is the primary statistic utilized to report the data amongst the three studies.  
The study conducted by Moss-Morris et al. was a randomized controlled trial with a 
relatively small number of participants, which consisted of IBS patients who had presented to a 
primary care office or general practitioner (n=64). The small sample size allowed strict 
monitoring of compliance to therapy. This was done by accounting for patient attendance and 
compliance with completing their questionnaires. Over 80% of the population at every point 
throughout this study attended their CBT therapy sessions, and completed the required 
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questionnaires. The results of this study reveal significantly lower severity of IBS symptoms 
occurred in the patients who received CBT, in comparison with the treatment as usual (TAU) 
group. Interestingly, these patients showed marked improvement immediately at the end of the 
study, and continued to improve at three and six months post-treatment. As depicted in Table 2 
below, the mean change from baseline in the patient population receiving CBT was 109 points 
on the IBS-SSS, compared to 29.5 in the TAU group, when measured at six months post 
treatment. The study notes that a 50-point change on the IBS-SSS is clinically significant. 83% 
of the population receiving CBT had a clinically significant reduction in their symptoms at six 
months post treatment.6 Additionally, 49% of the population receiving TAU reported clinically 
significant reduction in their symptoms at six months post-treatment.6 Only four participants 
within the experimental group reported that the intervention was not very effective, and no 
members reported the treatment as ineffective.6 All in all, this study reports an odds ratio of 12.2 
with an associated 95% confidence interval of 3.72-40.1.6 This odds ratio suggests a very strong 
likelihood that CBT as a treatment intervention leads to symptomatic reduction in patients with 
IBS.  
Table 2- IBS symptom evaluation through the IBS-SSS questionnaire amongst patients receiving
CBT versus TAU.




CBT 228.5 156.7 135.4 119.4
TAU 222.8 195.0 190.5 193.3
The study done by Jarrett et al. was a three-arm randomized controlled trial that had a 
slightly larger number of subjects, consisting of IBS patients recruited through community 
advertisement (n=188). Though the reports were analyzed on a slightly different scale than the 
other studies previously discussed, the results of this study were similar. A significant reduction 
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of IBS symptoms as measured by the IBS symptom score questionnaire was noted at 3 months, 6
months, and 12 months.  These results are further delineated below in Table 3. At 6 months after 
treatment initiation, patients receiving CBT reported a 26.6 decrease in their IBS symptom score 
questionnaire, compared with a 10.3 decrease in the usual care population.7 Odds ratio 
throughout the statistics within this study’s analyses were all large (i.e., greater than 2.3).7 The 
patients within this study also reported a significant increase in their work productivity. The 
study reports a p-value less than .001 in regard to the IBS symptom score reduction, and 
improvement of quality of life amongst the patients receiving CBT.7 The 95% confidence 
interval reported within this study at 6 months after the initiation of treatment for group receiving
CBT is -21 to -32, while the usual care group had a 95% confidence interval of -3 to -16.7 
Interestingly, this study applied further analysis of IBS symptomatic reduction by logging 
recordings of the change from baseline in a variety of specific symptoms that patients were 
experiencing. The study yielded results that suggest the largest symptomatic reduction was in 
abdominal pain and intestinal gas.7 Thirty-seven percent of patients receiving CBT in this study 
reported greater than 50% improvement in their abdominal pain/discomfort.7 Additionally, these 
patients reported significant increases in their quality of life and less absence from work due to 
their illness after receiving CBT for at least three months. Compliance to therapy and the 
assigned homework questionnaires were monitored throughout the study. Eighty-seven percent 
of subjects received at least seven of nine sessions, and 91% of patients met the expectations for 
the amount of homework that was to be completed.7 
Table 3- IBS symptom evaluation through the IBS symptom score questionnaire amongst 
patients receiving CBT or usual care. 
Baseline 3 Months 6 Months 12 Months
CBT 76 -28.5 -26.6 -25.6
Usual Care 64.9 -5.4 -10.3 -9.5
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The study performed by Lackner et al. was a randomized controlled parallel group trial 
consisting of a larger sample size (n=436). Of these participants 9% dropped out from the study 
due to varying demographic, psychological, and IBS–related variables.8 This study also showed 
significant reduction in the symptoms of IBS with standard CBT. However, the control group in 
this study showed a significant reduction in symptoms as well. The study notes that CBT 
outperformed IBS education on the IBS-SSS and overall symptomatic improvement but failed to 
produce any significant between group difference.8 At six months after the initiation of treatment 
the standard CBT group reported a -103.5 +/- 17 point decrease on their IBS-SSS questionnaire, 
compared to a 97.93 +/- 15.4 point decrease in the IBS education only sample.8 All changes from
baseline reported below in Table 4 are significant (p<.01). Eighty-nine percent of the participants
within this study were compliant with the treatment regimen, as indicated by attending at least 
eight of the ten CBT sessions.8  
Table 4- IBS symptom evaluation through the IBS-SSS questionnaire amongst patients receiving
CBT or IBS education alone.
Immediate Post -
Treatment
3 Months Post -
Treatment
6 Months Post -
Treatment
CBT -80.99 +/- 17.0 -103.2 +/-16.4 -103.5 +/- 17.7
IBS Education Only -84.43 +/- 14.6 -88.53 +/- 14.6 -97.93 +/- 15.4
DISCUSSION 
In summary, CBT is an effective treatment option for an array of mental health illnesses, 
as well as IBS. The results from all studies within this review show irrefutable evidence that 
CBT is a great treatment option to reduce the symptoms associated with IBS. Though CBT is a 
safe form of treatment with no black box warnings or long-term side effects, it may not be 
appropriate for every patient. For instance, individuals who have limited intellectual functioning 
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or cognitive impairment may not receive benefit from CBT as an intervention.9 One finding 
throughout these studies that raises concern over the true effect of CBT can be found within the 
Lackner et al study. The control group, which is patients receiving IBS education only, produced 
comparable findings to the CBT population. This suggests that a phenomenon other than CBT 
may be the causative agent in reducing one’s symptoms. Throughout the three studies, patients 
showed continued symptomatic improvement at six months, and in two of the studies, even at 
one year. Therefore, CBT can help patients learn skills to independently manage their conditions 
appropriately to some degree. A potential drawback from CBT is that the cost may not be 
accessible to those without insurance. Approximately 27.6 million people under the age of 65 are
uninsured and may be unable to afford this treatment option.10 Home therapy, or a cheaper 
alternative to treatment delivery may reduce this limitation. 
Each of the three studies presents limitations that need to be accounted for when making 
analyses. For instance, all of these studies focused on CBT in the adult population. More 
research needs to be conducted to determine effectiveness of CBT in regards to treating the 
pediatric IBS population. In the study by Moss-Morris et al., the majority of participants had 
severe IBS symptoms and were less disabled, and depressed than cohorts of comparable studies.6
A lower baseline level of anxiety or depression amongst study participants is a large potential 
confounding variable. Within the study by Jarrett et al., the majority of participants were 
educated Caucasian females.7 The final study by Lackner et al. relied upon mostly volunteers, 
which coincidentally were comprised of mostly women as well.8 Perhaps the biggest drawback 
within this study as aforementioned, was that the control group produced similar results to the 
treatment population. This leads one to consider if CBT is truly the agent that is reducing IBS 
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symptoms. This study suggests that education alone may lead to significant improvement of their
condition, without receiving any form of CBT. 
CONCLUSION 
In conclusion, CBT is a great option for those with insurance, and ample free time, as a 
means of treatment for IBS. Each study produced statistically significant results, which clearly 
answers the question of whether or not IBS can be effectively treated with CBT. Further studies 
need to be conducted that account for the limitations mentioned within this review. Gender 
differences, as well as a patients’ baseline anxiety levels and other mental health illnesses, must 
be accounted for to appropriately establish the impact that CBT has on a cohort. The longevity of
symptomatic relief that CBT can provide for these patients is a potential area of research to be 
expounded upon. Additionally, future studies can address the cost effectiveness of IBS treatment,
as Americans have one of the highest rates of underinsured or uninsured individuals. It is well 
known that CBT can effectively help those with mental health illnesses. However, a future area 
of research could focus on how CBT affects those with IBS that have very low baseline levels of 
anxiety or other mental health issues. All in all, these studies have done an excellent job in 
portraying the many benefits which cognitive behavioral therapy can provide for those suffering 
from IBS.
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